Cheng‐Hsu Chen

4k citations
189 papers · 3.1k · 3 hit papers · h-index 26

Impact in

  • Nephrology top 0.5%
    • Renal Diseases and Glomerulopathies
    • Dialysis and Renal Disease Management
    • Chronic Kidney Disease and Diabetes
    • Renal Transplantation Outcomes and Treatments

Papers in

    • Renal Diseases and Glomerulopathies 26
    • Dialysis and Renal Disease Management 26
    • Chronic Kidney Disease and Diabetes 13
    • Acute Kidney Injury Research 7
    • Renal Transplantation Outcomes and Treatments 31

Cheng‐Hsu Chen

176 papers receiving 3k citations

Cheng‐Hsu Chen's Hit Papers

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial 2023 · 195 citations
1950+1+2Years since publication50100150

Peers

Cheng‐Hsu Chen
Comparison fields: 5 of 115
  • Nephrology 1.1k
  • Transplantation 362
  • Hepatology 301
  • Gastroenterology 70
  • Immunology 177
Replace Julia Weinmann‐Menke with:
Julia Weinmann‐Menke Germany
Giuseppe D’Amico Italy
Antonio Dal Canton Italy
Teresa Rampino Italy
Krzysztof Mucha Poland
Steven R. Hays United States
Alexander Kainz Austria
Yoshifumi Ubara Japan
Jordi Bas Spain
Yaacov Ori Israel
Cheng‐Hsu Chen relative to Julia Weinmann‐Menke Germany Julia Weinmann‐Menke's profile →
Citations per field
00.5×2×4×6.4×
Julia Weinmann‐Menke · 1×
Citations per year

Countries citing papers authored by Cheng‐Hsu Chen

Since Specialization
Citations

This map shows the geographic impact of Cheng‐Hsu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Hsu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Hsu Chen more than expected).

Fields of papers citing papers by Cheng‐Hsu Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Hsu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Hsu Chen. The network helps show where Cheng‐Hsu Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Cheng‐Hsu Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cheng‐Hsu Chen Line = papers co-authored together Cheng‐Hsu Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 189 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2004270
2
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
Hit paper breakdown →
2023195
3
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
Hit paper breakdown →
2022163
4
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
Hit paper breakdown →
2023163
5 2006139
6 2004126
7 2011102
8 200496
9 200883
10 201683
11 200174
12 201068
13 200464
14 201851
15 200148
16 201545
17 201239
18 201635
19 201933
20 201531

About Cheng‐Hsu Chen

Cheng‐Hsu Chen is a scholar working on Nephrology, Transplantation, Hepatology, Epidemiology and Gastroenterology, having authored 189 papers that have together received 3.1k indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (31 papers), Renal Diseases and Glomerulopathies (26 papers), Dialysis and Renal Disease Management (26 papers), Chronic Kidney Disease and Diabetes (13 papers), Acute Kidney Injury Research (7 papers), Hepatitis B Virus Studies (7 papers), Genetic and Kidney Cyst Diseases (6 papers) and Hepatitis C virus research (4 papers). The work is most often cited by research in Nephrology (1.1k citations), Transplantation (362 citations), Hepatology (301 citations), Gastroenterology (70 citations) and Immunology (177 citations). Cheng‐Hsu Chen has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Kuo‐Hsiung Shu, Ming‐Ju Wu, Ya‐Wen Chuang, Shang-Feng Tsai, Wen‐Chin Lee, Tung‐Min Yu, John J. Fung, Shiguang Qian, Chi-Hung Cheng and Chi‐Hung Cheng. Their work appears in journals such as Renal Failure, Scientific Reports, Nephrology Dialysis Transplantation, BMC Nephrology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact